The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4.
Saved in:
| Title: | The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4. |
|---|---|
| Authors: | Chen H; Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.; Department of Oncology, Cangzhou People's Hospital, Cangzhou, China., Wang C; Department of Oncology, Cangzhou People's Hospital, Cangzhou, China., Dai H; Department of Oncology, Cangzhou People's Hospital, Cangzhou, China., Shi J; Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 46900195@hebmu.edu.cn. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Jan; Vol. 399 (1), pp. 665-681. Date of Electronic Publication: 2025 Jul 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
